Autophagy–Lysosome Pathway Dysfunction in Neurodegeneration and Cancer: Mechanisms and Therapeutic Opportunities
International Journal of Molecular Sciences · 29.12.2025 · 27 (1) · 366
DOI: 10.3390/ijms27010366 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.12.2025. Verfasst von Mingyang Du und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Chemistry and Life Science, Beijing University of Technology, 100124 Beijing, China. Hauptthemen laut MEDLINE: Lysosomes, Autophagy, Neurodegenerative Diseases, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for Beijing Municipal Universities.
Abstract (Originalsprache)
The autophagy–lysosome system is a master regulator of cellular homeostasis, integrating quality control, metabolism, and cell fate through the selective degradation of cytoplasmic components. Disruption of either autophagic flux or lysosomal function compromises this degradative pathway and leads to diverse pathological conditions. Emerging evidence identifies the autophagy–lysosome network as a central signaling hub that connects metabolic balance to disease progression, particularly in neurodegenerative disorders and cancer. Although cancer and neurodegenerative diseases exhibit seemingly opposite outcomes—uncontrolled proliferation versus progressive neuronal loss—both share common mechanistic foundations within the autophagy–lysosome axis. Here, we synthesize recent advances on the roles of autophagy and lysosomal mechanisms in neurodegenerative diseases and cancer, especially on how defects in lysosomal acidification, membrane integrity, and autophagosome–lysosome fusion contribute to toxic protein accumulation and organelle damage in Alzheimer’s and Parkinson’s diseases, while the same machinery is repurposed by tumor cells to sustain anabolic growth, stress tolerance, and therapy resistance. We also highlight emerging lysosome-centered therapeutic approaches, including small molecules that induce lysosomal membrane permeabilization, nanomedicine-based pH correction, and next-generation protein degradation technologies. Finally, we discuss the major challenges and future opportunities for translating these mechanistic insights into clinical interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biology, College of Chemistry and Life Science, Beijing University of Technology, 100124 Beijing, China.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for Beijing Municipal Universities
Zitieren
APA
Du, M., Yu, Y., Wang, J., & Ji, C. (2025). Autophagy–Lysosome Pathway Dysfunction in Neurodegeneration and Cancer: Mechanisms and Therapeutic Opportunities. International Journal of Molecular Sciences, 27(1), 366. https://doi.org/10.3390/ijms27010366
Vancouver
Du M, Yu Y, Wang J, Ji C. Autophagy–Lysosome Pathway Dysfunction in Neurodegeneration and Cancer: Mechanisms and Therapeutic Opportunities. International Journal of Molecular Sciences. 2025;27(1):366. doi:10.3390/ijms27010366
BibTeX
@article{Du2025,
author = {Du, Mingyang and Yu, Yang and Wang, Jiachang and Ji, Cuicui},
title = {Autophagy–Lysosome Pathway Dysfunction in Neurodegeneration and Cancer: Mechanisms and Therapeutic Opportunities},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {27},
number = {1},
pages = {366},
doi = {10.3390/ijms27010366}
}
EUVIMED